Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil and Vinorelbine in Metastatic Breast Cancer
NCT00159094Phase 2Unknown
- Sponsor
- Hematology Oncology Consultants
- Start
- Oct 2003
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pegylated liposomal doxorubicin and vinorelbine in breast cancer, sponsored by Hematology Oncology Consultants. Primary endpoint: Response rate. Status: unknown.
02
Drugs
pegylated liposomal doxorubicinvinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00159094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159094.